ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biodegradable Coated Drug-eluting Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16M16908
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Biodegradable Coated Drug eluting Stent Market Research Report 2024
BUY CHAPTERS

Global Biodegradable Coated Drug-eluting Stent Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16M16908
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Boston Scientific
Abbott
Terumo Corporation
Biotronik AG
Sino Medical
JWMS
Lepu Medical

Biodegradable Coated Drug-eluting Stent Market

The global Biodegradable Coated Drug-eluting Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Bioresorbable Drug-Eluting Stent (BDES) is a medical device used to treat coronary artery disease. It combines drug-eluting technology and degradable stent technology, aiming to improve some of the shortcomings of traditional metal drug-eluting stents.
From a downstream perspective, Coronary Heart Disease accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biodegradable Coated Drug-eluting Stent leading manufacturers including Medtronic, Boston Scientific, Abbott, Terumo Corporation, Biotronik, Sino Medical, JWMS, Lepu Medical, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biodegradable Coated Drug-eluting Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biodegradable Coated Drug-eluting Stent Market Report

Report Metric Details
Report Name Biodegradable Coated Drug-eluting Stent Market
Segment by Type
  • Diameter 2.25mm
  • Diameter 2.50mm
  • Diameter 2.75mm
  • Other
Segment by Application
  • Coronary Heart Disease
  • Peripheral Arterial Disease
  • Aortic Disease
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Boston Scientific, Abbott, Terumo Corporation, Biotronik, Sino Medical, JWMS, Lepu Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biodegradable Coated Drug-eluting Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biodegradable Coated Drug-eluting Stent Market report?

Ans: The main players in the Biodegradable Coated Drug-eluting Stent Market are Medtronic, Boston Scientific, Abbott, Terumo Corporation, Biotronik, Sino Medical, JWMS, Lepu Medical

What are the Application segmentation covered in the Biodegradable Coated Drug-eluting Stent Market report?

Ans: The Applications covered in the Biodegradable Coated Drug-eluting Stent Market report are Coronary Heart Disease, Peripheral Arterial Disease, Aortic Disease, Other

What are the Type segmentation covered in the Biodegradable Coated Drug-eluting Stent Market report?

Ans: The Types covered in the Biodegradable Coated Drug-eluting Stent Market report are Diameter 2.25mm, Diameter 2.50mm, Diameter 2.75mm, Other

1 Study Coverage
1.1 Introduction to Biodegradable Coated Drug-eluting Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biodegradable Coated Drug-eluting Stent Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Diameter 2.25mm
1.2.3 Diameter 2.50mm
1.2.4 Diameter 2.75mm
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Biodegradable Coated Drug-eluting Stent Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Coronary Heart Disease
1.3.3 Peripheral Arterial Disease
1.3.4 Aortic Disease
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biodegradable Coated Drug-eluting Stent Revenue Estimates and Forecasts 2020-2031
2.2 Global Biodegradable Coated Drug-eluting Stent Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biodegradable Coated Drug-eluting Stent Sales Estimates and Forecasts 2020-2031
2.4 Global Biodegradable Coated Drug-eluting Stent Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Biodegradable Coated Drug-eluting Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Biodegradable Coated Drug-eluting Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Diameter 2.25mm Market Size by Manufacturers
3.5.2 Diameter 2.50mm Market Size by Manufacturers
3.5.3 Diameter 2.75mm Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Biodegradable Coated Drug-eluting Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biodegradable Coated Drug-eluting Stent Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Biodegradable Coated Drug-eluting Stent Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biodegradable Coated Drug-eluting Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biodegradable Coated Drug-eluting Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Biodegradable Coated Drug-eluting Stent Sales and Revenue by Type (2020-2031)
6.4 North America Biodegradable Coated Drug-eluting Stent Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biodegradable Coated Drug-eluting Stent Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Biodegradable Coated Drug-eluting Stent Sales and Revenue by Type (2020-2031)
7.4 Europe Biodegradable Coated Drug-eluting Stent Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biodegradable Coated Drug-eluting Stent Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Biodegradable Coated Drug-eluting Stent Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Biodegradable Coated Drug-eluting Stent Sales and Revenue by Type (2020-2031)
9.4 Central and South America Biodegradable Coated Drug-eluting Stent Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biodegradable Coated Drug-eluting Stent Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Biodegradable Coated Drug-eluting Stent Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Biodegradable Coated Drug-eluting Stent Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biodegradable Coated Drug-eluting Stent Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.1.4 Medtronic Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Biodegradable Coated Drug-eluting Stent Sales by Product in 2024
11.1.6 Medtronic Biodegradable Coated Drug-eluting Stent Sales by Application in 2024
11.1.7 Medtronic Biodegradable Coated Drug-eluting Stent Sales by Geographic Area in 2024
11.1.8 Medtronic Biodegradable Coated Drug-eluting Stent SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Boston Scientific Biodegradable Coated Drug-eluting Stent Sales by Product in 2024
11.2.6 Boston Scientific Biodegradable Coated Drug-eluting Stent Sales by Application in 2024
11.2.7 Boston Scientific Biodegradable Coated Drug-eluting Stent Sales by Geographic Area in 2024
11.2.8 Boston Scientific Biodegradable Coated Drug-eluting Stent SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Business Overview
11.3.3 Abbott Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.3.4 Abbott Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbott Biodegradable Coated Drug-eluting Stent Sales by Product in 2024
11.3.6 Abbott Biodegradable Coated Drug-eluting Stent Sales by Application in 2024
11.3.7 Abbott Biodegradable Coated Drug-eluting Stent Sales by Geographic Area in 2024
11.3.8 Abbott Biodegradable Coated Drug-eluting Stent SWOT Analysis
11.3.9 Abbott Recent Developments
11.4 Terumo Corporation
11.4.1 Terumo Corporation Corporation Information
11.4.2 Terumo Corporation Business Overview
11.4.3 Terumo Corporation Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.4.4 Terumo Corporation Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Terumo Corporation Biodegradable Coated Drug-eluting Stent Sales by Product in 2024
11.4.6 Terumo Corporation Biodegradable Coated Drug-eluting Stent Sales by Application in 2024
11.4.7 Terumo Corporation Biodegradable Coated Drug-eluting Stent Sales by Geographic Area in 2024
11.4.8 Terumo Corporation Biodegradable Coated Drug-eluting Stent SWOT Analysis
11.4.9 Terumo Corporation Recent Developments
11.5 Biotronik
11.5.1 Biotronik Corporation Information
11.5.2 Biotronik Business Overview
11.5.3 Biotronik Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.5.4 Biotronik Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Biotronik Biodegradable Coated Drug-eluting Stent Sales by Product in 2024
11.5.6 Biotronik Biodegradable Coated Drug-eluting Stent Sales by Application in 2024
11.5.7 Biotronik Biodegradable Coated Drug-eluting Stent Sales by Geographic Area in 2024
11.5.8 Biotronik Biodegradable Coated Drug-eluting Stent SWOT Analysis
11.5.9 Biotronik Recent Developments
11.6 Sino Medical
11.6.1 Sino Medical Corporation Information
11.6.2 Sino Medical Business Overview
11.6.3 Sino Medical Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.6.4 Sino Medical Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sino Medical Recent Developments
11.7 JWMS
11.7.1 JWMS Corporation Information
11.7.2 JWMS Business Overview
11.7.3 JWMS Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.7.4 JWMS Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 JWMS Recent Developments
11.8 Lepu Medical
11.8.1 Lepu Medical Corporation Information
11.8.2 Lepu Medical Business Overview
11.8.3 Lepu Medical Biodegradable Coated Drug-eluting Stent Product Models, Descriptions and Specifications
11.8.4 Lepu Medical Biodegradable Coated Drug-eluting Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Lepu Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Biodegradable Coated Drug-eluting Stent Industry Chain
12.2 Biodegradable Coated Drug-eluting Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Biodegradable Coated Drug-eluting Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Biodegradable Coated Drug-eluting Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biodegradable Coated Drug-eluting Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biodegradable Coated Drug-eluting Stent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Medtronic Inc
Boston Scientific
Abbott
Terumo Corporation
Biotronik AG
Sino Medical
JWMS
Lepu Medical
List of Tables
 Table 1. Global Biodegradable Coated Drug-eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biodegradable Coated Drug-eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biodegradable Coated Drug-eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biodegradable Coated Drug-eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Biodegradable Coated Drug-eluting Stent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Biodegradable Coated Drug-eluting Stent Sales by Region (2020-2025) & (Units)
 Table 8. Global Biodegradable Coated Drug-eluting Stent Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Biodegradable Coated Drug-eluting Stent Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Biodegradable Coated Drug-eluting Stent Sales Share by Manufacturers (2020-2025)
 Table 12. Global Biodegradable Coated Drug-eluting Stent Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Biodegradable Coated Drug-eluting Stent Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Biodegradable Coated Drug-eluting Stent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Coated Drug-eluting Stent as of 2024)
 Table 16. Global Biodegradable Coated Drug-eluting Stent Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Biodegradable Coated Drug-eluting Stent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Biodegradable Coated Drug-eluting Stent Manufacturing Base and Headquarters
 Table 19. Global Biodegradable Coated Drug-eluting Stent Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Biodegradable Coated Drug-eluting Stent Sales by Type (2020-2025) & (Units)
 Table 23. Global Biodegradable Coated Drug-eluting Stent Sales by Type (2026-2031) & (Units)
 Table 24. Global Biodegradable Coated Drug-eluting Stent Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Biodegradable Coated Drug-eluting Stent Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Biodegradable Coated Drug-eluting Stent ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Biodegradable Coated Drug-eluting Stent Sales by Application (2020-2025) & (Units)
 Table 29. Global Biodegradable Coated Drug-eluting Stent Sales by Application (2026-2031) & (Units)
 Table 30. Biodegradable Coated Drug-eluting Stent High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Biodegradable Coated Drug-eluting Stent Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Biodegradable Coated Drug-eluting Stent Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Biodegradable Coated Drug-eluting Stent ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Biodegradable Coated Drug-eluting Stent Growth Accelerators and Market Barriers
 Table 37. North America Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Biodegradable Coated Drug-eluting Stent Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Biodegradable Coated Drug-eluting Stent Growth Accelerators and Market Barriers
 Table 40. Europe Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Biodegradable Coated Drug-eluting Stent Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Biodegradable Coated Drug-eluting Stent Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Biodegradable Coated Drug-eluting Stent Investment Opportunities and Key Challenges
 Table 47. Central and South America Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Biodegradable Coated Drug-eluting Stent Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Biodegradable Coated Drug-eluting Stent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Biodegradable Coated Drug-eluting Stent SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Boston Scientific Corporation Information
 Table 60. Boston Scientific Description and Major Businesses
 Table 61. Boston Scientific Product Models, Descriptions and Specifications
 Table 62. Boston Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Boston Scientific Sales Value Proportion by Product in 2024
 Table 64. Boston Scientific Sales Value Proportion by Application in 2024
 Table 65. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 66. Boston Scientific Biodegradable Coated Drug-eluting Stent SWOT Analysis
 Table 67. Boston Scientific Recent Developments
 Table 68. Abbott Corporation Information
 Table 69. Abbott Description and Major Businesses
 Table 70. Abbott Product Models, Descriptions and Specifications
 Table 71. Abbott Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Abbott Sales Value Proportion by Product in 2024
 Table 73. Abbott Sales Value Proportion by Application in 2024
 Table 74. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 75. Abbott Biodegradable Coated Drug-eluting Stent SWOT Analysis
 Table 76. Abbott Recent Developments
 Table 77. Terumo Corporation Corporation Information
 Table 78. Terumo Corporation Description and Major Businesses
 Table 79. Terumo Corporation Product Models, Descriptions and Specifications
 Table 80. Terumo Corporation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Terumo Corporation Sales Value Proportion by Product in 2024
 Table 82. Terumo Corporation Sales Value Proportion by Application in 2024
 Table 83. Terumo Corporation Sales Value Proportion by Geographic Area in 2024
 Table 84. Terumo Corporation Biodegradable Coated Drug-eluting Stent SWOT Analysis
 Table 85. Terumo Corporation Recent Developments
 Table 86. Biotronik Corporation Information
 Table 87. Biotronik Description and Major Businesses
 Table 88. Biotronik Product Models, Descriptions and Specifications
 Table 89. Biotronik Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Biotronik Sales Value Proportion by Product in 2024
 Table 91. Biotronik Sales Value Proportion by Application in 2024
 Table 92. Biotronik Sales Value Proportion by Geographic Area in 2024
 Table 93. Biotronik Biodegradable Coated Drug-eluting Stent SWOT Analysis
 Table 94. Biotronik Recent Developments
 Table 95. Sino Medical Corporation Information
 Table 96. Sino Medical Description and Major Businesses
 Table 97. Sino Medical Product Models, Descriptions and Specifications
 Table 98. Sino Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Sino Medical Recent Developments
 Table 100. JWMS Corporation Information
 Table 101. JWMS Description and Major Businesses
 Table 102. JWMS Product Models, Descriptions and Specifications
 Table 103. JWMS Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. JWMS Recent Developments
 Table 105. Lepu Medical Corporation Information
 Table 106. Lepu Medical Description and Major Businesses
 Table 107. Lepu Medical Product Models, Descriptions and Specifications
 Table 108. Lepu Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Lepu Medical Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biodegradable Coated Drug-eluting Stent Product Picture
 Figure 2. Global Biodegradable Coated Drug-eluting Stent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Diameter 2.25mm Product Picture
 Figure 4. Diameter 2.50mm Product Picture
 Figure 5. Diameter 2.75mm Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Biodegradable Coated Drug-eluting Stent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Coronary Heart Disease
 Figure 9. Peripheral Arterial Disease
 Figure 10. Aortic Disease
 Figure 11. Other
 Figure 12. Biodegradable Coated Drug-eluting Stent Report Years Considered
 Figure 13. Global Biodegradable Coated Drug-eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Biodegradable Coated Drug-eluting Stent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Biodegradable Coated Drug-eluting Stent Revenue Market Share by Region (2020-2031)
 Figure 17. Global Biodegradable Coated Drug-eluting Stent Sales (2020-2031) & (Units)
 Figure 18. Global Biodegradable Coated Drug-eluting Stent Sales (CAGR) by Region (2020-2031) (Units)
 Figure 19. Global Biodegradable Coated Drug-eluting Stent Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Volume Market Share in 2024
 Figure 21. Global Biodegradable Coated Drug-eluting Stent Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Diameter 2.25mm Revenue Market Share by Manufacturer in 2024
 Figure 24. Diameter 2.50mm Revenue Market Share by Manufacturer in 2024
 Figure 25. Diameter 2.75mm Revenue Market Share by Manufacturer in 2024
 Figure 26. Other Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Biodegradable Coated Drug-eluting Stent Sales Market Share by Type (2020-2031)
 Figure 28. Global Biodegradable Coated Drug-eluting Stent Revenue Market Share by Type (2020-2031)
 Figure 29. Global Biodegradable Coated Drug-eluting Stent Sales Market Share by Application (2020-2031)
 Figure 30. Global Biodegradable Coated Drug-eluting Stent Revenue Market Share by Application (2020-2031)
 Figure 31. North America Biodegradable Coated Drug-eluting Stent Sales YoY (2020-2031) & (Units)
 Figure 32. North America Biodegradable Coated Drug-eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 34. North America Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Type (2020- 2031)
 Figure 35. North America Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Application (2020-2031)
 Figure 37. North America Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Biodegradable Coated Drug-eluting Stent Sales YoY (2020-2031) & (Units)
 Figure 42. Europe Biodegradable Coated Drug-eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Type (2020-2031)
 Figure 45. Europe Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Application (2020-2031)
 Figure 47. Europe Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 49. France Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales YoY (2020-2031) & (Units)
 Figure 54. Asia-Pacific Biodegradable Coated Drug-eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 64. India Biodegradable Coated Drug-eluting Stent Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Biodegradable Coated Drug-eluting Stent Sales YoY (2020-2031) & (Units)
 Figure 66. Central and South America Biodegradable Coated Drug-eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Type (2021-2031)
 Figure 69. Central and South America Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Application (2020-2031)
 Figure 71. Central and South America Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Biodegradable Coated Drug-eluting Stent Sales YoY (2020-2031) & (Units)
 Figure 75. Middle East and Africa Biodegradable Coated Drug-eluting Stent Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Type (2021-2031)
 Figure 78. South America Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Biodegradable Coated Drug-eluting Stent Sales Volume (Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Biodegradable Coated Drug-eluting Stent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Biodegradable Coated Drug-eluting Stent Revenue (2020-2025) & (US$ Million)
 Figure 85. Biodegradable Coated Drug-eluting Stent Industry Chain Mapping
 Figure 86. Regional Biodegradable Coated Drug-eluting Stent Manufacturing Base Distribution (%)
 Figure 87. Global Biodegradable Coated Drug-eluting Stent Production Market Share by Region (2020-2031)
 Figure 88. Biodegradable Coated Drug-eluting Stent Production Process
 Figure 89. Regional Biodegradable Coated Drug-eluting Stent Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Biodegradable Drug Eluting Stents Market Research Report 2024
Global Biodegradable Polymer Drug eluting Stents BP DES Market Research Report 2024
Global Bioabsorbable Eluting Coronary Stent System Market Research Report 2024
Global Bioresorbable Stent System Market Research Report 2025
Global Biodegradable Coronary Stents Market Research Report 2024
Global Bioresorbable Drug Eluting Stents Market Research Report 2025
Biodegradable and Bioabsorbable Stents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bioresorbable Metals Cardiovascular Stents Market Research Report 2024
Global Drug Eluting Coronary Stent Market Research Report 2025
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Global Polymeric Bioabsorbable Stents Market Research Report 2024
Global Coronary Bioresorbable Scaffolds Market Research Report 2024
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Drug Eluting Peripheral Stents Market Research Report 2025
Global Biodegradable Scaffold Market Research Report 2024
Bioabsorbable Stents Sales Market
Global Biodegradable Materials for Vascular Stents Market Research Report 2024
Drug Eluting Stent System Market
Global Biodegradable Biliary Stent Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions